Novel Androgen Receptor Signaling. Inhibitors for Nonmetastatic Castration -Resistant Prostate Cancer: The Light at the End of the Tunnel-or an Oncoming Train?

Harrison Michael R.; Ramalingam Sundhar

首页> 外文期刊>Oncology >Novel Androgen Receptor Signaling. Inhibitors for Nonmetastatic Castration -Resistant Prostate Cancer: The Light at the End of the Tunnel-or an Oncoming Train?

【24h】

Novel Androgen Receptor Signaling. Inhibitors for Nonmetastatic Castration -Resistant Prostate Cancer: The Light at the End of the Tunnel-or an Oncoming Train?

机译：新型雄激素受体信号传导。非转移性去势抑制剂-抵抗性前列腺癌：隧道尽头的光还是即将来临的火车？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology 》 |2016年第4期| 共3页
作者
Harrison Michael R.; Ramalingam Sundhar;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Novel Androgen Receptor Signaling. Inhibitors for Nonmetastatic Castration -Resistant Prostate Cancer: The Light at the End of the Tunnel-or an Oncoming Train? [J] . Harrison Michael R., Ramalingam Sundhar Oncology . 2016 ,第4期

机译：新型雄激素受体信号传导。非转移性去势抑制剂-抵抗性前列腺癌：隧道尽头的光还是即将来临的火车？
2. Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors [J] . Saad Fred, B?gemann Martin, Suzuki Kazuhiro, Prostate Cancer and Prostatic Diseases . 2021 ,第2期

机译：治疗非容性阉割前列腺癌：对焦于第二代雄激素受体抑制剂
3. Novel therapeutic strategies for castration resistant prostate cancer: inhibition of persistent androgen production and androgen receptor mediated signaling. [J] . Molina A, Belldegrun A The Journal of Urology . 2011 ,第3期

机译：去势抵抗性前列腺癌的新治疗策略：抑制持续的雄激素生成和雄激素受体介导的信号传导。
4. Androgen Receptor Deregulation and the Transition to Castration Resistance in Prostate Cancer: Mechanisms and Potential Therapeutic Implications [C] . Karen E. Knudsen Genitourinary Cancers Symposium . 2011

机译：雄激素受体放松调节和前列腺癌抗阉割性的过渡：机制和潜在的治疗意义
5. Reprogramming androgen receptor and lysine-specific demethylase 1 transcriptome in castration-resistant prostate cancer [D] . Rizvi, Abbas Ali. 2015

机译：重编程雄激素受体和赖氨酸特异性脱甲基酶1转录组在去势抵抗性前列腺癌中
6. Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509) a Potent Androgen Receptor Antagonist in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort [O] . Matthew R. Smith, Emmanuel S. Antonarakis, Charles J. Ryan, -1

机译：高强度非转移性去势抵抗性前列腺癌队列研究：有效雄激素受体拮抗剂阿帕鲁胺（ARN-509）的安全性和抗肿瘤活性的第二阶段研究
7. Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer [O] . Arif Hussain, Abhishek Tripathi, Christopher Pieczonka, 2020

机译：雄激素剥夺治疗和雄激素受体抑制剂在非容性阉割前列腺癌患者中的骨健康效应

Novel Androgen Receptor Signaling. Inhibitors for Nonmetastatic Castration -Resistant Prostate Cancer: The Light at the End of the Tunnel-or an Oncoming Train?

著录项

相似文献

相关主题

期刊订阅